For discharged patients without suspected or confirmed VTE or other indication for anticoagulation, panel suggests not using anticoagulants
MONDAY, July 19, 2021 (HealthDay News) — A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).
For patients with COVID-19 who are being discharged from the hospital and who do not have suspected or confirmed venous thromboembolism or another indication for anticoagulation, the ASH guideline panel suggests not using anticoagulant outpatient thromboprophylaxis (conditional recommendation based on very low-certainty evidence).
When deciding whether to use postdischarge thromboprophylaxis, an individualized assessment of the patient’s risk for thrombosis and bleeding and shared decision-making are important. There are no validated risk assessment models for estimating thrombotic and bleeding risk for COVID-19 patients after discharge.
For patients judged to be at high thrombotic risk and low bleeding risk, the panel acknowledges that postdischarge thromboprophylaxis may be reasonable.
The recommendation is available for public comment, open to all ASH members and the public.
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism 
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE 
Elevated INR in Older Adults on Warfarin May Not Be Tied to Risk for Brain Bleeding After Head Trauma 
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
